A milestone of sorts took place on Monday March 3 when MarijuanaDoctors.com began airing a television commercial that looks to be the first ever marijuana commercial on a major TV network.
A milestone of sorts took place on Monday March 3 when MarijuanaDoctors.com began airing a television commercial that looks to be the first ever marijuana commercial on a major TV network. The spot began airing in New Jersey and is believed to be the first time that any major television network in the U.S. has allowed a commercial addressing the controversial subject matter and advertising the first ever medical marijuana service.
Major networks under the umbrella of Comcast - FOX, Food Network, and Bravo FX etc - have given the commercial the green light.
It wasn’t an easy launch: “Securing the airtime for our commercial on a major network was extremely difficult and at the same time, extremely satisfying,” stated Jason Draizin, Founder and CEO of MarijuanaDoctors.com, Inc.
He added: “The goal of MarijuanaDoctors.com is to bridge that gap between the patients who have a need for marijuana recommendations, and the doctors who write medical marijuana recommendations.” The company allows patients to fill out a form on their website to find a certified physician near their location.
The curious comparison in the commercial has a shady street dealer trying to push tainted sushi on an unsuspecting buyer and medical marijuana patients similarly forced to obtain their weed from the street. Hard to make the leap between an off-tuna roll (or that there even is such a thing as a sushi dealer) and bad pot, but the parallel was drawn in an attempt to prove the severity of consulting physicians in order to obtain medical marijuana for terminal and debilitating medical conditions, rather than reporting to illegal means.
“We felt the viewing public would agree that in the states providing safe access, continuing to obtain medicine illegally is as absurd as purchasing raw fish from a drug dealer,” concluded Draizin.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.